Herring, W. Joseph
Mukai, Yuki
Wang, Aobo
Lutkiewicz, Jeannine
Lombard, John F.
Lin, Li
Watkins, Molly
Broussard, David M.
Blobner, Manfred
Article History
Received: 17 March 2021
Accepted: 30 September 2021
First Online: 28 October 2021
Declarations
:
: Institutional review board committees at each site approved this randomized, active comparator-controlled, multi-site, parallel-group, double-blind safety study, conducted at 27 sites in 4 countries from December 2017 to September 2019. All participants provided written, informed consent.
: Not applicable.
: W.J.H., Y.M., A.W., J.L., J.F.L., L.L., and M.W. are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (MSD). D.M.B. declares funding research and consulting fees from Merck & Co., Inc., Kenilworth, NJ, USA. M.B. declares grants and personal fees from MSD, Haar, Germany; personal fees from GrĂ¼nenthal, Aachen, Germany; and personal fees from GE Healthcare, Helsinki, Finland.